Evidence map›Paper›PMID 40410226›Full record

ArticleScientific reports2025

QSPR and QSTR analysis to explore pharmacokinetic and toxicity properties of antifungal drugs through topological descriptors.

W Tamilarasi, B J Balamurugan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

W TamilarasiDepartment of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Chennai Campus, Vandalur-Kelambakkam Road, Chennai, Tamil Nadu, 600127, India.
B J BalamuruganDepartment of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Chennai Campus, Vandalur-Kelambakkam Road, Chennai, Tamil Nadu, 600127, India. balamurugan.bj@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 patients often develop serious fungal infections like Aspergillosis, Candidiasis, and Mucormycosis, which are treated with antifungal drugs like Amphotericin B, Posaconazole, and Isavuconazole. However, these treatments are often insufficient, leading researchers to explore drug combinations and analogs. In theoretical chemistry, a chemical molecule is converted into an isomorphic molecular graph, represented as G (V, E) by considering atom set V as vertices and bond set E as edges. Quantitative structure-activity/property/toxicity relationships (QSAR, QSPR, QSTR) modelling is a widely recognized discipline that correlates physicochemical and molecular descriptors with a drug's bioactivity to predict its standard pharmacological properties. In this article, the aforementioned drugs, as well as some Amphotericin B analogs, with their properties, are considered for QSPR/QSTR analysis. The QSPR/QSTR analysis is carried out using linear regression between the computed topological indices (based on degree and neighbourhood degree sum) and pharmacokinetic (ADMET) and toxicity properties (LD

Indexed as

Antifungal AgentsQuantitative Structure-Activity RelationshipAmphotericin BCOVID-19COVID-19 Drug TreatmentHumansNitrilesPyridinesSARS-CoV-2TriazolesAmphotericin BAntifungal AgentsisavuconazoleNitrilesposaconazolePyridinesTriazolesADMETAntifungal drugsLD50Linear regressionQSPR analysisTopological indices

Identifiers

PMID40410226
PMCPMC12102203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.